Flavia Borellini - Aug 16, 2021 Form 4 Insider Report for Viracta Therapeutics, Inc. (VIRX)

Role
Director
Signature
/s/ Michael Mueller, as Attorney-in-Fact
Stock symbol
VIRX
Transactions as of
Aug 16, 2021
Transactions value $
$0
Form type
4
Date filed
8/17/2021, 06:11 PM
Previous filing
Aug 17, 2021
Next filing
Jun 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRX Stock Option (Right to Buy) Award $0 +80K $0.00 80K Aug 16, 2021 Common Stock 80K $9.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One thirty-sixth (1/36) of the shares subject to the option shall vest monthly beginning on the one month anniversary of August 16, 2021 (the "Vesting Commencement Date"), subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date.